Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting in Patients With Inadequate Response to One or Several Conventional DMARDs Including Methotrexate in France. A Database Analysis Based on the ACTION Study
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
Price : $35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ReACTION
- Sponsors Bristol-Myers Squibb
- 06 Feb 2018 Status changed from active, no longer recruiting to completed.
- 01 Jun 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 03 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 Jan 2018, according to ClinicalTrials.gov record.